Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS South Australia Inc

Registered Charity 3104


Mailing address:

PO Box 322,
Modbury North,
South Australia 5092

1300 128 339

Office Hours:
Monday - Friday,
10am - 4pm

ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.


ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
DOCX Application Form (Word, 198 KB)
Why become a member?

Fibromyalgia drug being researched in Tuscaloosa

Monday 7 April 2014


From US news outlet



Fibromyalgia drug being researched in Tuscaloosa

By Nic Gulas
Updated: Sunday, March 30, 2014, 6:31 pm
Published: Sunday, March 30, 2014, 6:06 pm

TUSCALOOSA, Ala. (WIAT) — Fibromyalgia affects as many as 5 million people [in the US] over the age of 18. Approximately 80 to 90 percent of those are women.

The disorder causes aches and pain all over the body, with tender points along the neck, shoulders, hips and back.

People with fibromyalgia often experience numbness in the hands and feet, as well as sensitivity to light and extreme fatigue.

As such, treatment is often streamlined for each patient. Finding the right mix of medication and physical therapy can take time.

It can also be hard to diagnose, because the symptoms are often signs of so many other conditions.

Now, a Tuscaloosa-based biotech company is finished with phase two of testing for a drug that could help fibromyalgia patients.

It started 15 years ago in an effort to find ways to relieve the pain of people suffering from irritable bow[e]l syndrome.

The research is on the right track towards finding a cure for fibromyalgia.

“There’s two medicines that hit the viruses in three different ways that actually will put the viruses to sleep, and then sort of miraculously, after a while, their body just sort of goes back to the way it was supposed to be,” said Dr. Skip Pridgen, the CEO of Innovative Med Concepts.

The research has already gotten attention from fibromyalgia sufferers worldwide.

The next step is winning over the medical community. Trials will enter Phase 2B in coming weeks, with a third and final phase to follow.

“There was a patient questionnaire that patients could fill out and seeing their comments,” said Rick Burch, the president of Innovative Med Concepts.

2014 WIAT-TV CBS42


The above originally appeared here.


Arrow right

More Fibromyalgia News


Arrow right

More Multimedia



blog comments powered by Disqus
Previous Previous Page